SKIN SQUAMOUS CELL CARCINOMA
Clinical trials for SKIN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SKIN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SKIN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps the immune syst…
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Immune cells injected directly into skin tumors show promise in early trial
Disease control Recruiting nowThis early-phase study tests whether injecting special immune cells (NK cells) from donors directly into skin cancer tumors is safe and can kill cancer cells. About 40 adults with basal or squamous cell skin cancer will receive either standard NK cells or a more potent type (TGF-…
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Kirsten Johnson • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Can a simple cream take the sting out of cancer mapping?
Symptom relief Recruiting nowThis study tests whether EMLA numbing cream can reduce pain from Technetium 99 injections used in lymphoscintigraphy, a standard mapping procedure for skin cancers like melanoma. About 100 adults with skin cancer will receive either EMLA cream or a placebo before the injection. R…
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 04, 2026 16:31 UTC